• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖诱导的视网膜毛细血管基底膜增厚:Sorbinil的预防作用

Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.

作者信息

Frank R N, Keirn R J, Kennedy A, Frank K W

出版信息

Invest Ophthalmol Vis Sci. 1983 Nov;24(11):1519-24.

PMID:6642931
Abstract

Normotensive and spontaneously hypertensive rats fed a 30% galactose diet until 15-21 months of age developed significant (P less than 0.05) retinal capillary basement membrane thickening, compared with animals fed a standard test diet. Animals on the high galactose diet containing 250 mg/kg of the aldose reductase inhibitor, Sorbinil, did not develop basement membrane thickening. No cytologic abnormalities of pericytes or endothelial cells were noted, and pericyte:endothelial cell nuclear ratios did not differ in the various experimental groups. This model reproduces a characteristic lesion of diabetes mellitus in non-diabetic animals, and should facilitate study of the biochemical mechanisms of basement membrane thickening.

摘要

正常血压和自发性高血压大鼠在15至21个月大时喂食30%半乳糖饮食,与喂食标准试验饮食的动物相比,出现了显著(P小于0.05)的视网膜毛细血管基底膜增厚。喂食含250mg/kg醛糖还原酶抑制剂索比尼尔的高半乳糖饮食的动物未出现基底膜增厚。未观察到周细胞或内皮细胞的细胞学异常,不同实验组的周细胞:内皮细胞核比率也无差异。该模型在非糖尿病动物中再现了糖尿病的特征性病变,应有助于研究基底膜增厚的生化机制。

相似文献

1
Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.半乳糖诱导的视网膜毛细血管基底膜增厚:Sorbinil的预防作用
Invest Ophthalmol Vis Sci. 1983 Nov;24(11):1519-24.
2
Galactose-induced retinal microangiopathy in rats.半乳糖诱导的大鼠视网膜微血管病变
Invest Ophthalmol Vis Sci. 1995 Feb;36(2):490-6.
3
Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.索比尼尔对半乳糖喂养大鼠模型中糖尿病样视网膜病变的预防作用
Invest Ophthalmol Vis Sci. 1995 Nov;36(12):2368-80.
4
Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.半乳糖诱导的视网膜毛细血管基底膜增厚中IV型胶原蛋白和层粘连蛋白的增加——醛糖还原酶抑制剂的预防作用
Exp Eye Res. 1990 Mar;50(3):269-80. doi: 10.1016/0014-4835(90)90211-c.
5
Aldose reductase activity and basement membrane thickening.醛糖还原酶活性与基底膜增厚。
Metabolism. 1986 Apr;35(4 Suppl 1):35-40. doi: 10.1016/0026-0495(86)90185-x.
6
Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.视网膜和视神经中的醛糖还原酶与周细胞-内皮细胞接触
Invest Ophthalmol Vis Sci. 1989 Nov;30(11):2293-9.
7
Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.醛糖还原酶、糖尿病与视网膜内界膜增厚
Invest Ophthalmol Vis Sci. 1987 Nov;28(11):1867-9.
8
Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.醛糖还原酶抑制剂可预防大鼠的糖尿病样视网膜病变。
Invest Ophthalmol Vis Sci. 1989 Nov;30(11):2285-92.
9
Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.视网膜毛细血管:半乳糖血症所致的基底膜增厚可被醛糖还原酶抑制剂预防。
Science. 1983 Sep 16;221(4616):1177-9. doi: 10.1126/science.6612330.
10
Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat.索比尼尔不能阻止半乳糖诱导的大鼠肾小球毛细血管基底膜增厚。
Diabetologia. 1990 Sep;33(9):515-21. doi: 10.1007/BF00404137.

引用本文的文献

1
Proteomic Analysis of Aqueous Humor Identified Clinically Relevant Molecular Targets for Neovascular Complications in Diabetic Retinopathy.房水的蛋白质组学分析确定了糖尿病视网膜病变新生血管并发症的临床相关分子靶点。
Mol Cell Proteomics. 2025 Apr;24(4):100953. doi: 10.1016/j.mcpro.2025.100953. Epub 2025 Mar 19.
2
Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review.醛糖还原酶作为糖尿病视网膜病变防治的关键靶点:综述
Biomedicines. 2024 Mar 27;12(4):747. doi: 10.3390/biomedicines12040747.
3
Breaking barriers: exploring mechanisms behind opening the blood-brain barrier.
打破壁垒:探索血脑屏障开放的背后机制。
Fluids Barriers CNS. 2023 Nov 28;20(1):87. doi: 10.1186/s12987-023-00489-2.
4
Modeling angiogenesis in the human brain in a tissue-engineered post-capillary venule.在组织工程化的毛细血管后微静脉中模拟人脑血管生成。
Angiogenesis. 2023 May;26(2):203-216. doi: 10.1007/s10456-023-09868-7. Epub 2023 Feb 16.
5
The Role of Different Retinal Imaging Modalities in Predicting Progression of Diabetic Retinopathy: A Survey.不同视网膜成像模式在预测糖尿病视网膜病变进展中的作用:一项调查。
Sensors (Basel). 2022 May 4;22(9):3490. doi: 10.3390/s22093490.
6
The blood-brain barrier in systemic infection and inflammation.全身性感染和炎症中的血脑屏障。
Cell Mol Immunol. 2021 Nov;18(11):2489-2501. doi: 10.1038/s41423-021-00757-x. Epub 2021 Sep 30.
7
Genome-wide polygenic risk score for retinopathy of type 2 diabetes.2 型糖尿病视网膜病变的全基因组多基因风险评分。
Hum Mol Genet. 2021 May 29;30(10):952-960. doi: 10.1093/hmg/ddab067.
8
Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy.视网膜毛细血管基底膜增厚:在糖尿病性视网膜病变发病机制中的作用。
Prog Retin Eye Res. 2021 May;82:100903. doi: 10.1016/j.preteyeres.2020.100903. Epub 2020 Sep 18.
9
Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review.糖尿病视网膜病变药物治疗与技术的当前进展:一项系统综述
J Ophthalmol. 2018 Jan 17;2018:1694187. doi: 10.1155/2018/1694187. eCollection 2018.
10
Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).醛糖还原酶、眼部糖尿病并发症与局部 Kinostat(®)的研发。
Prog Retin Eye Res. 2016 Sep;54:1-29. doi: 10.1016/j.preteyeres.2016.04.006. Epub 2016 Apr 19.